Australian experience with ibrutinib in patients with relapsed/refractory mantle cell lymphoma: a study from the Lymphoma and Related Diseases Registry
Details
Publication Year 2023,Volume 64,Issue #3,Page 621-627
Journal Title
Leukemia & Lymphoma
Publication Type
Research article
Publisher
Taylor & Francis
Department(s)
Clinical Haematology
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2024-01-16 04:29:25
Last Modified: 2024-01-16 04:53:14

© 2024 The Walter and Eliza Hall Institute of Medical Research. Access to this website is subject to our Privacy Policy and Terms of Use

An error has occurred. This application may no longer respond until reloaded. Reload 🗙